Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of Jan-05-2024

  1. Alpine Immune Sciences

    World Rank (Jan-05-2024)
    8,232
    Market Cap (Jan-05-2024)
    1.075 Billion USD
    World Rank (Jul-30-2023)
    11,771
    Market Cap (Jul-30-2023)
    0.585 Billion USD
    World Rank (Dec-25-2022)
    15,748
    Market Cap (Dec-25-2022)
    0.299 Billion USD
    World Rank (Jan-07-2022)
    16,596
    Market Cap (Jan-07-2022)
    0.31 Billion USD
    Annual Revenue in USD
    30 Million USD
    Annual Operating Income in USD
    -58 Million USD
    Annual Net Income in USD
    -58 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
  2. Phibro Animal Health Corporation

    World Rank (Jan-05-2024)
    12,974
    Market Cap (Jan-05-2024)
    0.471 Billion USD
    World Rank (Jul-30-2023)
    11,793
    Market Cap (Jul-30-2023)
    0.582 Billion USD
    World Rank (Dec-25-2022)
    11,658
    Market Cap (Dec-25-2022)
    0.563 Billion USD
    World Rank (Jan-07-2022)
    10,512
    Market Cap (Jan-07-2022)
    0.82 Billion USD
    Annual Revenue in USD
    942 Million USD
    Annual Net Income in USD
    49 Million USD
    Annual Results for Period Ending
    Jun-2022 ending year
    Headquarters Country
    Company Profile
    Phibro Animal Health is a contributing to a healthy and affordable food supply company by helping farmers responsibly care for their animals. The company products are Beef Cattle, Swine, Poultry, Dairy Cattle, Aqua, Mineral Nutrition, Ethanol and Performance Products. The company annual revenue is 799 million USD and 1,600 employees as on 2020. The headquarters is in USA.
  3. Caribou Biosciences Inc.

    World Rank (Jan-05-2024)
    13,113
    Market Cap (Jan-05-2024)
    0.460 Billion USD
    World Rank (Jul-30-2023)
    11,795
    Market Cap (Jul-30-2023)
    0.582 Billion USD
    World Rank (Dec-25-2022)
    14,290
    Market Cap (Dec-25-2022)
    0.376 Billion USD
    World Rank (Jan-07-2022)
    10,790
    Market Cap (Jan-07-2022)
    0.78 Billion USD
    Annual Revenue in USD
    14 Million USD
    Annual Operating Income in USD
    -106 Million USD
    Annual Net Income in USD
    -99 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
  4. Evolus

    World Rank (Jan-05-2024)
    11,577
    Market Cap (Jan-05-2024)
    0.592 Billion USD
    World Rank (Jul-30-2023)
    11,861
    Market Cap (Jul-30-2023)
    0.577 Billion USD
    World Rank (Dec-25-2022)
    14,106
    Market Cap (Dec-25-2022)
    0.386 Billion USD
    World Rank (Jan-07-2022)
    15,668
    Market Cap (Jan-07-2022)
    0.35 Billion USD
    Annual Revenue in USD
    148 Million USD
    Annual Operating Income in USD
    -58 Million USD
    Annual Net Income in USD
    -74 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
  5. Entrada Therapeutics Inc.

    World Rank (Jan-05-2024)
    13,007
    Market Cap (Jan-05-2024)
    0.469 Billion USD
    World Rank (Jul-30-2023)
    11,889
    Market Cap (Jul-30-2023)
    0.574 Billion USD
    World Rank (Dec-25-2022)
    12,819
    Market Cap (Dec-25-2022)
    0.470 Billion USD
    World Rank (Jan-07-2022)
    15,307
    Market Cap (Jan-07-2022)
    0.37 Billion USD
    Headquarters Country
  6. Pharvaris N.V.

    World Rank (Jan-05-2024)
    7,301
    Market Cap (Jan-05-2024)
    1.326 Billion USD
    World Rank (Jul-30-2023)
    11,900
    Market Cap (Jul-30-2023)
    0.573 Billion USD
    World Rank (Dec-25-2022)
    15,021
    Market Cap (Dec-25-2022)
    0.335 Billion USD
    World Rank (Jan-07-2022)
    11,928
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Headquarters Country
    Company Profile
    Pharvaris is a biotechnology sector company related clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Headquarters is in Netherlands.
  7. Theravance Biopharma

    World Rank (Jan-05-2024)
    11,722
    Market Cap (Jan-05-2024)
    0.577 Billion USD
    World Rank (Jul-30-2023)
    11,975
    Market Cap (Jul-30-2023)
    0.565 Billion USD
    World Rank (Dec-25-2022)
    9,878
    Market Cap (Dec-25-2022)
    0.761 Billion USD
    World Rank (Jan-07-2022)
    9,685
    Market Cap (Jan-07-2022)
    0.96 Billion USD
    Headquarters Country
  8. Design Therapeutics, Inc.

    World Rank (Jan-05-2024)
    19,654
    Market Cap (Jan-05-2024)
    0.143 Billion USD
    World Rank (Jul-30-2023)
    11,986
    World Rank (Dec-25-2022)
    11,986
    Market Cap (Dec-25-2022)
    0.533 Billion USD
    World Rank (Jan-07-2022)
    9,455
    Market Cap (Jan-07-2022)
    1.00 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -35 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Design Therapeutics, INC is a biotechnology company focused on molecules are designed to selectively bind to genetic repeat sequences, modulate gene expression either by restoring or blocking transcription and restore cellular health. The headquarters is in USA.
  9. Organogenesis Holdings

    World Rank (Jan-05-2024)
    12,742
    Market Cap (Jan-05-2024)
    0.490 Billion USD
    World Rank (Jul-30-2023)
    12,042
    Market Cap (Jul-30-2023)
    0.560 Billion USD
    World Rank (Dec-25-2022)
    14,958
    Market Cap (Dec-25-2022)
    0.339 Billion USD
    World Rank (Jan-07-2022)
    9,086
    Market Cap (Jan-07-2022)
    1.06 Billion USD
    Annual Revenue in USD
    450 Million USD
    Annual Operating Income in USD
    22 Million USD
    Annual Net Income in USD
    16 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Organogenesis Holdings is a Regenerative Medicine company focused on empowering healing through the development, manufacturing and sale of products for the advanced wound care and surgical and sports medicine markets. The headquarters is in USA.
    Facts About Company
    Organogenesis Holdings company annual revenue was 450 million USD and annual net income was 15 million USD as on Dec-2022.
  10. iRadimed Corporation

    World Rank (Jan-05-2024)
    11,707
    Market Cap (Jan-05-2024)
    0.578 Billion USD
    World Rank (Jul-30-2023)
    12,122
    Market Cap (Jul-30-2023)
    0.553 Billion USD
    World Rank (Dec-25-2022)
    14,719
    Market Cap (Dec-25-2022)
    0.352 Billion USD
    World Rank (Jan-07-2022)
    12,689
    Market Cap (Jan-07-2022)
    0.57 Billion USD
    Annual Revenue in USD
    53 Million USD
    Annual Operating Income in USD
    16 Million USD
    Annual Net Income in USD
    13 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country

Share

Ads